Process View
The directed orientation of T cell signaling molecules and associated membrane rafts towards a chemokine gradient or a contact point with antigen presenting cell.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "establishment of t cell polarity"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.993 | Human | |
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.985 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.972 | Human | |
IL1B | interleukin 1, beta | 0.879 | ||
IDE | insulin-degrading enzyme | 0.858 | ||
IL8 | interleukin 8 | 0.814 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.805 | Human | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.777 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.720 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.669 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.657 | Human | |
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.556 | Human | |
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.555 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.455 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.397 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.363 | Human | |
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.350 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.348 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.308 | Human | |
CCL3 | chemokine (C-C motif) ligand 3 | 0.291 | Human | |
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.287 | ||
IFNG | interferon, gamma | 0.267 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.253 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.231 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.216 | ||
TNF | tumor necrosis factor | 0.165 | ||
MYL9 | myosin, light chain 9, regulatory | 0.156 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.151 | ||
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.147 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.147 | ||
RGS1 | regulator of G-protein signaling 1 | 0.134 | ||
CD83 | CD83 molecule | 0.133 | ||
IL10 | interleukin 10 | 0.111 | ||
SELE | selectin E | 0.105 | ||
DARC | Duffy blood group, chemokine receptor | 0.104 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.099 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.092 | Human | |
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.091 | ||
IL7R | interleukin 7 receptor | 0.086 | ||
IL2RB | interleukin 2 receptor, beta | 0.080 | ||
IL2RG | interleukin 2 receptor, gamma | 0.074 | ||
ASCC2 | activating signal cointegrator 1 complex subunit 2 | 0.073 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.068 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.064 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.063 | ||
FPR3 | formyl peptide receptor 3 | 0.061 | ||
IL32 | interleukin 32 | 0.059 | ||
CH25H | cholesterol 25-hydroxylase | 0.056 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.049 | ||
ARRB1 | arrestin, beta 1 | 0.048 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.046 | ||
SLAMF8 | SLAM family member 8 | 0.045 | ||
MEN1 | multiple endocrine neoplasia I | 0.045 | ||
FLNA | filamin A, alpha | 0.044 | ||
UBD | ubiquitin D | 0.043 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.043 | Human | |
CCR3 | chemokine (C-C motif) receptor 3 | 0.040 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.040 | ||
IL1R2 | interleukin 1 receptor, type II | 0.040 | ||
SLAMF7 | SLAM family member 7 | 0.037 | ||
BCL2A1 | BCL2-related protein A1 | 0.037 | ||
FLNB | filamin B, beta | 0.034 | ||
IL21R | interleukin 21 receptor | 0.033 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.032 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.031 | ||
KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.031 | ||
XCL2 | chemokine (C motif) ligand 2 | 0.031 | Human | |
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.031 | ||
IL10RA | interleukin 10 receptor, alpha | 0.030 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.030 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.029 | ||
CLEC10A | C-type lectin domain family 10, member A | 0.028 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.028 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.028 | Human | |
CD80 | CD80 molecule | 0.028 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.028 | Human | |
TARP | TCR gamma alternate reading frame protein | 0.027 | ||
MSC | musculin | 0.027 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.026 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.026 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.025 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.024 | ||
APOC1 | apolipoprotein C-I | 0.023 | ||
INHBA | inhibin, beta A | 0.023 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.023 | Human | |
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.023 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.022 | ||
GNLY | granulysin | 0.022 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.022 | ||
MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.021 | ||
DNASE1L3 | deoxyribonuclease I-like 3 | 0.020 | ||
RGS16 | regulator of G-protein signaling 16 | 0.020 | ||
SRGN | serglycin | 0.019 | ||
CD69 | CD69 molecule | 0.019 | ||
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.019 | ||
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.018 | ||
CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.018 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.018 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.018 | ||
PLEK | pleckstrin | 0.017 | ||
TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.017 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.017 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.017 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.016 | ||
IL1A | interleukin 1, alpha | 0.016 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.016 | ||
ICOS | inducible T-cell co-stimulator | 0.016 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.015 | ||
C2 | complement component 2 | 0.015 | ||
PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.015 | ||
TM7SF4 | transmembrane 7 superfamily member 4 | 0.015 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.015 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.015 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.015 | ||
XCL1 | chemokine (C motif) ligand 1 | 0.015 | Human | |
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.015 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.014 | Human | |
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.014 | ||
PDPN | podoplanin | 0.014 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.014 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.013 | ||
IL13 | interleukin 13 | 0.013 | ||
GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 0.013 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.013 | ||
BATF | basic leucine zipper transcription factor, ATF-like | 0.013 | ||
CD1B | CD1b molecule | 0.013 | ||
IL18R1 | interleukin 18 receptor 1 | 0.013 | ||
GAB2 | GRB2-associated binding protein 2 | 0.013 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.013 | ||
CD40LG | CD40 ligand | 0.013 | ||
RUNX3 | runt-related transcription factor 3 | 0.013 | ||
CD48 | CD48 molecule | 0.013 | ||
IRF4 | interferon regulatory factor 4 | 0.013 | ||
IL1RN | interleukin 1 receptor antagonist | 0.013 | ||
PRDM1 | PR domain containing 1, with ZNF domain | 0.013 | ||
IL2RA | interleukin 2 receptor, alpha | 0.012 | ||
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.012 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.012 | ||
PLAU | plasminogen activator, urokinase | 0.011 | ||
IL11 | interleukin 11 | 0.011 | ||
IL4 | interleukin 4 | 0.011 | ||
CHIT1 | chitinase 1 (chitotriosidase) | 0.011 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.011 | ||
GPR109B | G protein-coupled receptor 109B | 0.011 | ||
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.011 | ||
CCR6 | chemokine (C-C motif) receptor 6 | 0.011 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.011 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.011 | ||
LAG3 | lymphocyte-activation gene 3 | 0.011 | ||
MMP19 | matrix metallopeptidase 19 | 0.011 | ||
C3AR1 | complement component 3a receptor 1 | 0.011 | ||
CD247 | CD247 molecule | 0.011 | ||
PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.011 | ||
NKG7 | natural killer cell group 7 sequence | 0.011 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.010 | ||
CCBP2 | chemokine binding protein 2 | 0.010 | ||
CD1A | CD1a molecule | 0.010 | ||
CD160 | CD160 molecule | 0.010 | ||
DPT | dermatopontin | 0.010 | ||
P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 0.010 |